Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 219Thoracic 6Gynecologic 4Genitourinary 3Plasma cell 2Other hematologic neoplasm 2Dermatologic 2CNS 2Breast 2Sarcoma 1Other solid neoplasm 1Other 1Lymphoid 1

Conditions

Mucositis 2Xerostomia 1Squamous Cell Carcinoma of Head and Neck 1Neuritis 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Therapeutics 2oxycodone-acetaminophen 1maltodextrin 1Tramadol 1Psychology, Positive 1Psychiatric Rehabilitation 1Pentoxifylline 1Oxaliplatin 1Orphenadrine 1Octreotide 1Morphine 1Methods 1Methadone 1Lidocaine 1Leucovorin 1Ketorolac Tromethamine 1Ketorolac 1Ketamine 1Hydromorphone 1Hydrocodone 1Gabapentin 1Fluorouracil 1Fentanyl 1Exercise 1Bupivacaine 1Bariatric Surgery 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Fluorouracil × Other × Clear all
NCT05590117 2022-10-21

Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer

Tanta University

Phase EARLY_PHASE1 Unknown
48 enrolled
GastrointestinalOther

Colonic Neoplasms, Neuritis, Colorectal Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡